In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

F1 news, rumours and gossip: Formula 1 latest updates on teams, driver transfer market and contracts Follow the latest news from the world of Formula 1 ahead of the 2026 season. Saturday 28 February ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

LiveF1 is a powerful Python toolkit for accessing and analyzing Formula 1 data in real-time or from historical archives. It's designed for developers, analysts, and F1 fans building applications ...